Clinical trial
DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia and High Risk of Developing Acute Respiratory Distress Syndrome
NCT04836780 is registered in ClinicalTrials.gov with Hospital Universitario Infanta Leonor as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia and High Risk of Developing Acute Respiratory Distress Syndrome
- Lead sponsor
- Hospital Universitario Infanta Leonor
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 10, 2021
- Completion date
- March 30, 2023
- Enrollment
- 126 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory distress syndrome, covid-19, pneumonia, viral